Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 130

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 130
---
 so amended and restated, will be the bylaws of the Surviving Corporation until thereafter
changed or amended as provided therein or by applicable law.

At the Effective Time, the directors and officers of the Surviving
Corporation will be the respective individuals who served as the directors and officers of Merger Sub as of immediately prior to the Effective Time, until their respective successors are duly elected and qualified, or their earlier death,
resignation or removal.

Closing and Effective Time

The Closing will occur on the third (3rd) business day (or such other date agreed by STAAR and Alcon) after the satisfaction or waiver of all
of the closing conditions of the Merger (described below under the caption “—Conditions to the Closing of the Merger”), other than those conditions to be satisfied at the Closing. As soon as practicable on the date of the
Closing, Alcon, Merger Sub, and STAAR will cause the Certificate of Merger to be executed and filed with the Secretary of State of the State of Delaware in accordance with the DGCL. The Merger will become effective upon the time and date of the
filing of the Certificate of Merger or such later date and time as agreed by STAAR and Alcon and specified in the Certificate of Merger.

Merger Consideration

Common Stock

At the Effective Time, and without any further action on the part of the parties or any of STAAR stockholders, each share of STAAR common stock
then outstanding immediately prior to the Effective Time (other than Excluded Shares and Dissenting Shares, which will be canceled and cease to exist and will not be converted into or represent the right to receive the Merger Consideration at the
Effective Time, as discussed further in “Proposal 1: Adoption of the Merger Agreement—Appraisal Rights”), will be automatically converted into the right to receive the Merger Consideration of $28.00 per share in cash,
without interest, subject to any withholding of taxes.

If, between August 4, 2025 and the Effective Time, the outstanding shares of
STAAR common stock are changed into a different number of shares or a different class of shares by reason of any stock dividend, subdivision, reorganization, reclassification, recapitalization, stock split or similar event, the Merger Consideration
will be equitably adjusted to proportionally reflect such change.

Treatment of STAAR Long-Term Incentive Awards

STAAR Options. At the Effective Time,